Tag: Drug
Centre Cancels Jackson Laboratories’ Licences After Rajasthan Maternal Deaths; WHO Seeks Details
India's Union Health Ministry has revoked the manufacturing licences of Jackson Laboratories' facilities in Punjab and Himachal Pradesh following joint inspections by the Central...
Government Simplifies Form 11 Rules to Accelerate Pharmaceutical R&D and Innovation
In a major move to boost pharmaceutical research and innovation, the Union Ministry of Health and Family Welfare has proposed a draft amendment to...
Jan Vishwas Act: Government Reduces Penalties for Minor Food and Drug Violations
In a major step toward trust-based governance, the Government of India has operationalised key reforms under the Jan VishwasAct, 2026. The initiative rationalises minor offences...
GSK Launches Tender Offer to Acquire Precision Oncology Innovator Nuvalent, Inc.at $124.00
GSK plc has officially commenced a tender offer to acquire all issued and outstanding shares of Class A and Class B common stock of Nuvalent,...
NPPA Launches Unified Digital Platform Integrating Pharma Jan Samadhan with Pharma Sahi Daam
In a major boost to citizen-centric digital governance, the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has officially...
Novartis strikes a $1.9B partnership with Antares Therapeutics to tackle “undruggable” cancer targets.
Novartis has entered into a strategic collaboration and license agreement with Antares Therapeutics to discover and develop next-generation small molecule oncology treatments. The transaction...
